Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Müller

Showing results (531-540 of 651) with videos related to

Pageof 66
Sort By:
Oncogene|February 27, 2022
Targeted siRNA nanocarrier: a platform technology for cancer treatmentNicole Bäumer, Jessica Tiemann, Annika Scheller, et al.
Leukemia|February 18, 2021
Selective elimination of immunosuppressive T cells in patients with multiple myelomaMohamed H S Awwad, Abdelrahman Mahmoud, Heiko Bruns, et al.
Nature Communications|January 19, 2024
DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblastsMariana Shumliakivska, Guillermo Luxán, Inga Hemmerling, et al.
Blood|January 6, 2023
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myelomaNicola Giesen, Manik Chatterjee, Christof Scheid, et al.
Hemasphere|May 8, 2025
Age-stratified machine learning identifies divergent prognostic significance of molecular alterations in AMLJan-Niklas Eckardt, Waldemar Hahn, Rhonda E Ries, et al.
Plos One|January 3, 2018
Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk PredictionMichele Pohlen, Nils H Thoennissen, Jan Braess, et al.
Frontiers in Immunology|October 24, 2018
Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic EffectsLei Wang, Ming Ni, Angela Hückelhoven-Krauss, et al.
Journal of Hematology & Oncology|January 16, 2019
Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemiaAlva Rani James, Michael P Schroeder, Martin Neumann, et al.
Leukemia|June 21, 2020
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapyMaxi Wass, Stefanie Göllner, Birgit Besenbeck, et al.
Blood|June 30, 2023
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysisAlexandra M Poos, Nina Prokoph, Moritz J Przybilla, et al.
Pageof 66

Showing results (531-540 of 651) with videos related to

Sort By:
Pageof 66
Oncogene|February 27, 2022
Targeted siRNA nanocarrier: a platform technology for cancer treatmentNicole Bäumer, Jessica Tiemann, Annika Scheller, et al.
Leukemia|February 18, 2021
Selective elimination of immunosuppressive T cells in patients with multiple myelomaMohamed H S Awwad, Abdelrahman Mahmoud, Heiko Bruns, et al.
Nature Communications|January 19, 2024
DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblastsMariana Shumliakivska, Guillermo Luxán, Inga Hemmerling, et al.
Blood|January 6, 2023
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myelomaNicola Giesen, Manik Chatterjee, Christof Scheid, et al.
Hemasphere|May 8, 2025
Age-stratified machine learning identifies divergent prognostic significance of molecular alterations in AMLJan-Niklas Eckardt, Waldemar Hahn, Rhonda E Ries, et al.
Plos One|January 3, 2018
Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk PredictionMichele Pohlen, Nils H Thoennissen, Jan Braess, et al.
Frontiers in Immunology|October 24, 2018
Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic EffectsLei Wang, Ming Ni, Angela Hückelhoven-Krauss, et al.
Journal of Hematology & Oncology|January 16, 2019
Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemiaAlva Rani James, Michael P Schroeder, Martin Neumann, et al.
Leukemia|June 21, 2020
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapyMaxi Wass, Stefanie Göllner, Birgit Besenbeck, et al.
Blood|June 30, 2023
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysisAlexandra M Poos, Nina Prokoph, Moritz J Przybilla, et al.
Pageof 66